La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Rat And NotS. Breit

List of bibliographic references

Number of relevant bibliographic references: 160.
Ident.Authors (with country if any)Title
000019 Karima Maaroufi [France, Tunisie] ; Laurence Had-Aissouni [France] ; Christophe Melon [France] ; Mohsen Sakly [Tunisie] ; Hafedh Abdelmelek [Tunisie] ; Bruno Poucet [France] ; Etienne Save [France]Spatial learning, monoamines and oxidative stress in rats exposed to 900 MHz electromagnetic field in combination with iron overload
000028 Sylvia Navailles [France] ; Lea Milan [France] ; Hanane Khalki [France] ; Giuseppe Di Giovanni [Royaume-Uni, Malte] ; Mélanie Lagiere [France] ; Philippe De Deurwaerdere [France]Noradrenergic Terminals Regulate L-DOPA-derived Dopamine Extracellular Levels in a Region-dependent Manner in Parkinsonian Rats
000049 Omar Ouachikh [France] ; Wisam Dieb [France] ; Franck Durif [France] ; Aziz Hafidi [France]Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats
000076 M. Lagière [France] ; S. Navailles [France] ; L. Mignon [États-Unis] ; A. Roumegous [France] ; M.-F. Chesselet [États-Unis] ; P. De Deurwaerdère [France]The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates
000079 Jean-Michel Reymann [France] ; Florian Naudet [France] ; Morgane Pihan [France] ; Stephan Saïkali [France] ; Bruno Laviolle [France] ; Danièle Bentue-Ferrer [France]Subthalamic nucleus modulates social and anxogenic-like behaviors
000095 A. Daoust [France] ; E. L. Barbier [France] ; S. Bohic [France]Manganese enhanced MRI in rat hippocampus: A correlative study with synchrotron X-ray microprobe
000097 P. M. Abedi [France, Maroc] ; C. Delaville [France] ; P. De Deurwaerdere [France] ; W. Benjelloun [Maroc] ; A. Benazzouz [France]INTRAPALLIDAL ADMINISTRATION OF 6-HYDROXYDOPAMINE MIMICS IN LARGE PART THE ELECTROPHYSIOLOGICAL AND BEHAVIORAL CONSEQUENCES OF MAJOR DOPAMINE DEPLETION IN THE RAT
000109 Omar Ouachikh [France] ; Wisam Dieb [France] ; Franck Durif [France] ; Aziz Hafidi [France]Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area
000202 Fabrice Billet [France] ; Jean Costentin [France] ; Nathalie Dourmap [France]Influence of corticostriatal δ-opioid receptors on abnormal involuntary movements induced by L-DOPA in hemiparkinsonian rats
000296 Timothy P. Gilmour [États-Unis] ; Brigitte Piallat [France] ; Christopher A. Lieu [États-Unis] ; Kala Venkiteswaran [États-Unis] ; Renuka Ramachandra [États-Unis] ; Anand N. Rao [États-Unis] ; Andrew C. Petticoffer [États-Unis] ; Matthew A. Berk [États-Unis] ; Thyagarajan Subramanian [États-Unis]The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats
000314 Sylvia Navailles [France] ; Philippe De Deurwaerdere [France]Presynaptic control of serotonin on striatal dopamine function
000346 Giselle Charron [France] ; Evelyne Doudnikoff [France] ; Alexis Laux [France] ; Amandine Berthet [France] ; Gregory Porras [France] ; Marie-Hélène Canron [France] ; Pedro Barroso-Chinea [France] ; QIN LI [République populaire de Chine] ; CHUAN QIN [République populaire de Chine] ; Marika Nosten-Bertrand [France] ; Bruno Giros [France] ; François Delalande [France] ; Alain Van Dorsselaer [France] ; Anne Vital [France] ; Yannick Goumon [France] ; Erwan Bezard [France, République populaire de Chine]Endogenous morphine-like compound immunoreactivity increases in parkinsonism
000350 S. Derrey [France] ; W. Ouelaa [France] ; M. Lecointre [France] ; D. Maltete [France] ; N. Chastan [France] ; A. M. Leroi [France] ; F. Proust [France] ; P. Freger [France] ; J. Weber [France] ; G. Gourcerol [France]EFFECT OF UNILATERAL SUBTHALAMIC DEEP BRAIN STIMULATION ON RAT DIGESTIVE MOTOR ACTIVITY
000367 Brigitte Spinnewyn [France] ; Christelle Charnet [France] ; Sylvie Cornet [France] ; Veronique Roubert [France] ; Pierre-Etienne Chabrier [France] ; Michel Auguet [France]An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats
000369 Erwan Bezard [France] ; Serge Przedborski [États-Unis]A Tale on Animal Models of Parkinson's Disease
000438 Sébastien Paillusson [France] ; Maddalena Tasselli [France] ; Thibaud Lebouvier [France] ; Maxime Michaël Mahe [France] ; Julien Chevalier [France] ; Mandy Biraud [France] ; Chystelle Cario-Toumaniantz [France] ; Michel Neunlist [France] ; Pascal Derkinderen [France]α-Synuclein expression is induced by depolarization and cyclic AMP in enteric neurons
000453 A. Beyeler [France] ; N. Kadiri [France] ; S. Navailles [France] ; M. Ben Boujema [France] ; F. Gonon [France] ; C. Le Moine [France] ; C. Gross [France] ; P. De Deurwaerdere [France]STIMULATION OF SEROTONIN2C RECEPTORS ELICITS ABNORMAL ORAL MOVEMENTS BY ACTING ON PATHWAYS OTHER THAN THE SENSORIMOTOR ONE IN THE RAT BASAL GANGLIA
000465 Kwamivi Dzahini [France] ; Christine Dentresangle [France] ; Marion Le Cavorsin [France] ; Anne Bertrand [France] ; Isabelle Detraz [France] ; Marc Savasta [France] ; Vincent Leviel [France]Pre-synaptic glutamate-induced activation of DA release in the striatum after partial nigral lesion
000484 Dawn M. Eagle [Royaume-Uni] ; Christelle Baunez [France]Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition
000507 A. Faure [France] ; P. Leblanc-Veyrac [France] ; N. El Massioui [France]DOPAMINE AGONISTS INCREASE PERSEVERATIVE INSTRUMENTAL RESPONSES BUT DO NOT RESTORE HABIT FORMATION IN A RAT MODEL OF PARKINSONISM
000514 Holly M. Brothers [États-Unis] ; Yannick Marchalant [France] ; Gary L. Wenk [États-Unis]Caffeine attenuates lipopolysaccharide-induced neuroinflammation
000593 Samareh Azeredo Da Silveira [Suisse] ; Bernard L. Schneider [Suisse] ; Carmen Cifuentes-Diaz [France] ; Daniel Sage [Suisse] ; Toufik Abbas-Terki [Suisse] ; Takeshi Iwatsubo [Japon] ; Michaël Unser [France] ; Patrick Aebischer [Suisse]Phosphorylation does not prompt, nor prevent, the formation of α-synuclein toxic species in a rat model of Parkinson's disease
000612 Vincent Henry [France] ; Vincent Paille [France] ; Faustine Lelan [France] ; Philippe Brachet [France] ; Philippe Damier [France]Kinetics of Microglial Activation and Degeneration of Dopamine-Containing Neurons in a Rat Model of Parkinson Disease Induced by 6-Hydroxydopamine
000613 Jean-Francois Desaphy [Italie] ; Antonella Dipalma [Italie] ; Michela De Bellis [Italie] ; Teresa Costanza [Italie] ; Christelle Gaudioso [France] ; Patrick Delmas [France] ; Alfred L. Jr George [États-Unis] ; Diana Conte Camerino [Italie]Involvement of voltage-gated sodium channels blockade in the analgesic effects of orphenadrine
000645 Stefan Schuster [Allemagne] ; Evelyne Doudnikoff [France] ; Daniella Rylander [Suède] ; Amandine Berthet [France] ; Incarnation Aubert [France] ; Carina Ittrich [Allemagne] ; Bertrand Bloch [France] ; M. Angela Cenci [Suède] ; D. James Surmeier [États-Unis] ; Bastian Hengerer [Allemagne] ; Erwan Bezard [France]Antagonizing L-type Ca2+ Channel Reduces Development of Abnormal Involuntary Movement in the Rat Model of L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia
000723 Imane Nafia [France] ; Diane B. Re [France] ; Frédérique Masmejean [France] ; Christophe Melon [France] ; Philippe Kachidian [France] ; Lydia Kerkerian-Le Goff [France] ; André Nieoullon [France] ; Laurence Had-Aissouni [France]Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction
000727 Juan Esteban Ferrario [France] ; Argelia Esperanza Rojas-Mayorquin [France] ; Marisa Saldana-Ortega [France] ; Cristiane Salum [France] ; Margarete Zanardo Gomes [France] ; Stéphane Hunot [France] ; Rita Raisman-Vozari [France]Pleiotrophin receptor RPTP-ζ/β expression is up-regulated by L-DOPA in striatal medium spiny neurons of parkinsonian rats
000730 Gaëlle Bouchez [France] ; Luc Sensebe [France] ; Patrick Vourc'H [France] ; Lucette Garreau [France] ; Sylvie Bodard [France] ; Angélique Rico [France] ; Denis Guilloteau [France] ; Pierre Charbord [France] ; Jean-Claude Besnard [France] ; Sylvie Chalon [France]Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease
000752 Sarah Vautier [France] ; Aline Milane [France] ; Christine Fernandez [France] ; Marion Buyse [France] ; Helene Chacun [France] ; Robert Farinotti [France]Interactions between antiparkinsonian drugs and ABCB1/P-glycoprotein at the blood-brain barrier in a rat brain endothelial cell model
000758 Christine Winter [Allemagne] ; Christoph Lemke [Allemagne] ; Reinhard Sohr [Allemagne] ; Wassilios Meissner [Allemagne, France] ; Daniel Harnack [Allemagne] ; Georg Juckel [Allemagne] ; Rudolf Morgenstern [Allemagne] ; Andreas Kupsch [Allemagne]High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat
000772 Stéphane Woerly [France] ; Sébastien Fort [France] ; Isabelle Pignot-Paintrand [France] ; Cécile Cottet [France] ; Carole Carcenac [France] ; Marc Savasta [France]Development of a Sialic Acid-Containing Hydrogel of Poly[N-(2-hydroxypropyl) methacrylamide] : Characterization and Implantation Study
000774 E. Y. Pioli [France] ; W. Meissner [France] ; R. Sohr [Allemagne] ; C. E. Gross [France] ; E. Bezard [France] ; B. H. Bioulac [France]DIFFERENTIAL BEHAVIORAL EFFECTS OF PARTIAL BILATERAL LESIONS OF VENTRAL TEGMENTAL AREA OR SUBSTANTIA NIGRA PARS COMPACTA IN RATS
000775 Dieter Scheller [Allemagne] ; Nick Dürrafiller [France] ; Paul Moser [France] ; Roger D. Porsolt [France]Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the rat
000777 A. Marighetto [France] ; S. Valerio [France] ; J. N. Philippin [France] ; V. Bertaina-Anglade [France] ; C. Drieu La Rochelle [France] ; R. Jaffard [France] ; P. Morain [France]Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents
000795 Margarete Zanardo Gomes [Brésil] ; Rita Raisman-Vozari [France] ; Elaine A. Del Bel [Brésil]A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway
000797 Stéphanie Pain [France] ; Laurence Barrier [France] ; Julie Deguil [France] ; Serge Milin [France] ; Alain Piriou [France] ; Bernard Fauconneau [France] ; Guylène Page [France]A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats
000845 Pauline Sibille [France] ; Sébastien Lopez [France] ; Isabelle Brabet [France] ; Omella Valenti [États-Unis] ; Nadia Oueslati [France] ; Florence Gaven [France] ; Cyril Goudet [France] ; Hugues-Olivier Bertrand [France] ; Jacques Neyton [France] ; Michael J. Marino [États-Unis] ; Marianne Amalric [France] ; Jean-Philippe Pin [France] ; Francine C. Acher [France]Synthesis and biological evaluation of 1 -amino -2 -phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists
000864 SHUHONG GUO [République populaire de Chine] ; JINGQI YAN [République populaire de Chine, France] ; TANGBIN YANG [République populaire de Chine] ; XIANQIANG YANG [République populaire de Chine] ; Erwan Bezard [République populaire de Chine] ; BAOLU ZHAO [République populaire de Chine]Protective Effects of Green Tea Polyphenols in the 6-OHDA Rat Model of Parkinson's Disease Through Inhibition of ROS-NO Pathway
000871 V. Vialou [France] ; L. Balasse [France] ; S. Dumas [France] ; B. Giros [France] ; S. Gautron [France]Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain
000898 N. A. Do Thi [France] ; P. Saillour [France] ; L. Ferrero [France] ; T. Paunio [Finlande] ; J. Mallet [France]Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
000A15 Delphine C. Michel [France] ; Véronique Nerriere-Daguin ; Régis Josien ; Philippe Brachet ; Philippe Naveilhan ; Isabelle NeveuDendritic cell recruitment following xenografting of pig fetal mesencephalic cells into the rat brain
000A35 Naomi P. Visanji [Canada] ; Mark J. Millan [France] ; Jonathan M. Brotchie [Canada]Actions at sites other than D3 receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats
000A88 Giinter U. Höglinger [France, Allemagne] ; Annie Lannuzel [France] ; Myriam Escobar Khondiker [France, Allemagne] ; Patrick P. Michel [France] ; Charles Duyckaerts [France] ; Jean Feger [France] ; Pierre Champy [France] ; Annick Prigent [France] ; Fadia Medja [France] ; Anne Lombes [France] ; Wolfgang H. Oertel [Allemagne] ; Merle Ruberg [France] ; Etienne C. Hirsch [France]The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
000B04 R. Robichon [France] ; A. Jaafar [France] ; M. Terqui [France] ; P. Brachet [France] ; M. Peschanski [France]Pig xenografts to the immunocompetent rat brain : Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains
000B16 Irene R. E. Taravini [Argentine] ; Juan E. Ferrario [France] ; Jean Delbe [France] ; Laure Ginestet [France] ; Thomas Debeir [France] ; José Courty [France] ; M. Gustavo Murer [Argentine] ; Oscar S. Gershanik [Argentine] ; Rita Raisman-Vozari [France]Immunodetection of heparin-binding growth associated molecule (pleiotrophin) in striatal intemeurons
000B24 Nathalie Turle-Lorenzo [France] ; Nathalie Breysse [France] ; Christelle Baunez [France] ; Marianne Amalric [France]Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease
000B31 Thomas Debeir [France] ; Laure Ginestet [France] ; Chantal Francois [France] ; Stéphanie Laurens [France] ; Jean-Claude Martel [France] ; Philippe Chopin [France] ; Marc Marien [France] ; Francis Colpaert [France] ; Rita Raisman-Vozari [France]Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus
000B42 Véronique Sgambato-Faure [France] ; Virginie Buggia [France] ; Frangois Gilbert [Canada] ; Daniel Levesque [Canada] ; Alim-Louis Benabid [France] ; Francois Berger [France]Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-lnduced behavioral sensitization in dyskinetic rats
000B50 Carine Chassain [France] ; Guy Bielicki [France] ; Jean-Pierre Donnat [France] ; Jean-Pierre Renou [France] ; Alain Eschalier [France] ; Franck Durif [France]Cerebral glutamate metabolism in Parkinson's disease : an in vivo dynamic 13C NMS study in the rat
000C11 Roberto Coccurello [France] ; Nathalie Breysse [France] ; Marianne Amalric [France]Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats
000C15 Vincent Paille [France] ; Philippe Brachet [France] ; Philippe Damier [France]Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease
000C30 Christophe Jollivet [France] ; Anne Aubert-Pouessel [France] ; Anne Clavreul [France] ; Marie-Claire Venier-Julienne [France] ; Claudia N. Montero-Menei [France] ; Jean-Pierre Benoit [France] ; Philippe Menei [France]Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease
000C32 Jill L. Smith [France] ; Jeong-Sun Ju [France] ; Bithika M. Saha [France] ; Brad A. Racette [France, États-Unis] ; Jonathan S. Fisher [France]Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin-stimulated glucose transport in rat skeletal muscle
000C36 Jean-Jacques Bacci [France] ; Philippe Kachidian [France] ; Lydia Kerkerian-Le Goff [France] ; Pascal Salin [France]Intralaminar thalamic nuclei lesions: Widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia
000C53 Juan E. Ferrario [Argentine] ; Irene R. E. Taravini [Argentine] ; Sophie Mourlevat [France] ; Andrea Stefano [Argentine] ; Marina A. Delfino [Argentine] ; Rita Raisman-Vozari [France] ; M. Gustavo Murer [Argentine] ; Merle Ruberg [France] ; Oscar Gershanik [Argentine]Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system
000C56 N. A. Do Thi [France] ; P. Saillour [France] ; L. Ferrero [France] ; I. F. Dedieu [France] ; J. Mallet [France] ; T. Paunio [France, Finlande]Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease
000C60 N. Hamaue [Japon] ; M. Minami [Japon] ; M. Terado [Japon] ; M. Hirafuji [Japon] ; T. Endo [Japon] ; M. Machida [Japon] ; T. Hiroshige [Japon] ; A. Ogata [Japon] ; K. Tashiro [Japon] ; H. Saito [Japon] ; S. H. Parvez [France]Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus
000C68 Elsa Y. Pioli [France] ; Sandra Dovero [France] ; Bernard H. Bioulac [France] ; Christian E. Gross [France] ; Erwan Bezard [France]Asymmetrically lesioned mesencephalon in healthy rodents: call for caution
000C80 G. Chouvet [France] ; N. Urbain [France] ; N. Vautrelle [France] ; L. Dahan [France] ; B. Astier [France] ; B. Renaud [France]Vigilance et noyaux gris centraux : observations expérimentales et possibles implications dans la maladie de Parkinson
000D38 A. Lannuzel [France] ; P. P. Michel [France] ; G. U. Höglinger [France] ; P. Champy [France] ; A. Jousset [France] ; F. Medja [France] ; A. Lombes [France] ; F. Darios [France] ; C. Gleye [France] ; A. Laurens [France] ; R. Hocquemiller [France] ; E. C. Hirsch [France] ; M. Ruberg [France]The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism
000D62 Nicolas Bruet [France] ; Francois Windels [France] ; Carole Carcenac [France] ; Claude Feuerstein [France] ; Anne Bertrand [France] ; Annie Poupard [France] ; Marc Savasta [France]Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: Increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats
000D71 Mauro Maccarrone [Italie] ; Paolo Gubellini [France, Italie] ; Monica Bari [Italie] ; Barbara Picconi [Italie] ; Natalia Battista [Italie] ; Diego Centonze [Italie] ; Giorgio Bernardi [Italie] ; Alessandro Finazzi-Agro [Italie] ; Paolo Calabresi [Italie]Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism
000D73 Asteria Luzardo-Alvarez [Espagne] ; M. Begona Delgado-Charro [France] ; José Blanco-Mendez [Espagne]In vivo lontophoretic administration of ropinirole hydrochloride
000D82 S. Baker [France] ; E. Moyse [France] ; F. Jourdan [France] ; F. Colpaert [France] ; J. C. Martel [France] ; M. Marien [France]Effects of the α2-ADRENORECEPTOR antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: Selective protection against neuronal death
000D85 Céline Perier [France] ; Concepcio Marin [Espagne] ; Anna Jimenez [Espagne] ; Mercè Bonastre [Espagne] ; Eduardo Tolosa [Espagne] ; Etienne C. Hirsch [France]Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats
000D89 Benoit Melchior [France] ; Véronique Nerriere-Daguin [France] ; David-A. Laplaud [France] ; Séverine Remy [France] ; Sandrine Wiertlewski [France] ; Isabelle Neveu [France] ; Philippe Naveilhan [France] ; Susan O. Meakin [Canada] ; Philippe Brachet [France]Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection
000D90 Günter U. Höglinger [France] ; Géraldine Carrard [France] ; Patrick P. Michel [France] ; Fadia Medja [France] ; Anne Lombes [France] ; Merle Ruberg [France] ; Bertrand Friguet [France] ; Etienne C. Hirsch [France]Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease
000E00 Günter U. Höglinger [France, Allemagne] ; Jean Feger [France] ; Annick Prigent [France] ; Patrick P. Michel [France] ; Karine Parain [France] ; Pierre Champy [France] ; Merle Ruberg [France] ; Wolfgang H. Oertel [Allemagne] ; Etienne C. Hirsch [France]Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
000E39 J. Feger [France] ; M. Pessigliore [France] ; C. Francois [France] ; L. Tremblay [France] ; E. Hirsch [France]Modèles expérimentaux de la maladie de Parkinson
000E93 Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France]Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat
000E94 T. Debeir [France] ; M. Marien [France] ; P. Chopin [France] ; J.-C. Martel [France] ; F. Colpaert [France] ; R. Raisman-Vozari [France]Protective effects of the α2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat
000E97 Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Francois Huguet [France] ; Bernard Fauconneau [France]Progressive alteration of neuronal dopamine transporter activity in a rat injured by an intranigral injection of MPP+
000F26 Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France]Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in Parkinsonian rats
000F41 Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France]Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture
000F45 A. D. Smith [États-Unis] ; M. Amalric [France] ; G. F. Koob [États-Unis] ; M. J. Zigmond [États-Unis]Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time
000F56 Yoshimi Misu [Japon] ; Nobuya Furukawa [Japon] ; Nobutaka Arai [Japon] ; Takeaki Miyamae [Japon] ; Yoshio Goshima [Japon] ; Kiyohide Fujita [Japon]DOPA causes glutamate release and delayed neuron death by brain ischemia in rats
000F77 E. Lehtonen [Belgique] ; F. Bonnaud [France] ; C. Melas [Belgique] ; A. Lubansu [Belgique] ; B. Malgrange [Belgique] ; A. Chtarto [Belgique] ; T. Velu [Belgique] ; J. Brotchi [Belgique] ; M. Levivier [Belgique] ; M. Peschanski [France] ; L. Tenenbaum [Belgique]AAV2 vectors mediate efficient and sustained transduction of rat embryonic ventral mesencephalon
001024 Zhong-Ge Ni [France] ; Rabia Bouali-Benazzouz [France] ; Dong-Ming Gao [République populaire de Chine] ; Alim-Louis Benabid [France] ; Abdelhamid Benazzouz [France]Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats
001032 Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Feger [France]Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain
001042 J.-C. Lievens [France] ; P. Salin [France] ; A. Nieoullon [France] ; L. Kerkerian-Le Goff [France]Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum
001049 Laurent Groc [États-Unis, France] ; Laurent Bezin [États-Unis, France] ; Jane A. Foster [États-Unis] ; HAO JIANG [États-Unis] ; Tangella S. Jackson [États-Unis] ; Dinah Weissmann [France] ; Robert A. Levine [États-Unis]Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development
001062 Christine Dentresangle [France] ; Marion Le Cavorsin [France] ; Marc Savasta [France] ; Vincent Leviel [France]Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra
001063 Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Alain Piriou [France] ; Bernard Fauconneau [France]Impairment of the neuronal dopamine transporter activity in MPP+-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors
001065 Nicolas Bruet [France] ; Francois Windels [France] ; Anne Bertrand [France] ; Claude Feuerstein [France] ; Annie Poupard [France] ; Marc Savasta [France]High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats
001081 Adrian Newman-Tancredi [France] ; Didier Cussac [France] ; Mauricette Brocco [France] ; Jean-Michel Rivet [France] ; Christine Chaput [France] ; Manuelle Touzard [France] ; Valérie Pasteau [France] ; Mark J. Millan [France]Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra
001090 Olivier Guillin [France] ; Jorge Diaz [France] ; Patrick Carroll [France] ; Nathalie Griffon [France] ; Jean-Charles Schwartz [France] ; Pierre Sokoloff [France]BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
001094 Stéphanie Barc [France] ; Guylène Page [France] ; Bernard Fauconneau [France] ; Laurence Barrier [France] ; Francois Huguet [France]A new in vitro approach for investigating the MPTP effect on DA uptake
001170 Z. G. Ni [France] ; D. M. Gao [République populaire de Chine] ; A. L. Benabid [France] ; A. Benazzouz [France]Unilateral lesion of the nigrostriatal pathway induces a transient decrease of firing rate with no change in the firing pattern of neurons of the parafascicular nucleus in the rat
001171 E. Aliaga [Chili] ; C. Carcamo [Chili] ; J. Abarca [Chili] ; L. Tapia-Arancibia [France] ; G. Bustos [Chili]Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway
001195 G. Orieux [France] ; C. Francois [France] ; J. Feger [France] ; J. Yelnik [France] ; M. Vila [France] ; M. Ruberg [France] ; Yves Agid [France] ; E. C. Hirsch [France]Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease
001204 C. Perier [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; J. Feger [France]Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion
001206 P. Missy [France] ; M-C Lanhers [France] ; Y. Grignon [France] ; M. Joyeux [France] ; D. Burnel [France]In vitro and in vivo studies on chelation of manganese
001214 C. Perier [France] ; M. Vila [France] ; J. Feger [France] ; Yves Agid [France] ; E. C. Hirsch [France]Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats
001219 Pierre Dubus [France] ; Baptiste Faucheux [France] ; Florence Boissiere [France] ; Alexis Groppi [France] ; Claude Vital [France] ; T. Anne Vital [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] ; Jean Philippe Merlio [France]Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease
001223 A. Benazzouz [France, République populaire de Chine] ; D. M. Gao [République populaire de Chine] ; Z. G. Ni [France] ; B. Piallat [France] ; R. Bouali-Benazzouz [France] ; A. L. Benabid [France]Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat
001228 N. Schulmann-Choron [France] ; P. Chevallier [France] ; J. De Ceaurriz [France] ; C. Souleau [France]Determination of selenium in rat brain by synchrotron radiation X-ray fluorescence
001232 C. Scherfler [Autriche] ; Z. Puschban [Autriche] ; I. Ghorayeb [France] ; G. P. Goebel [Autriche] ; F. Tison [France] ; K. Jellinger [Autriche] ; Werner Poewe [Autriche] ; G. K. Wenning [Autriche]Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy)
001235 W.-J. Gu [France] ; N. Abbas [France] ; M. Z. Lagunes [France] ; A. Parent [France] ; L. Pradier [France] ; G. A. Bohme [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; R. Raisman-Vozari [France] ; A. Brice [France]Cloning of rat parkin cDNA and distribution of parkin in rat brain
001242 D. C. Rogers [Royaume-Uni] ; B. Costall [Royaume-Uni] ; A. M. Domeney [France] ; P. A. Gerrard [Royaume-Uni] ; M. Greener [Royaume-Uni] ; M. E. Kelly [Royaume-Uni] ; J. J. Hagan [Royaume-Uni] ; A. J. Hunter [Royaume-Uni]Anxiolytic profile of ropinirole in the rat, mouse and common marmoset
001256 Développement des neurones dopaminergiques et environnement matriciel : analyse in vivo et in vitro du rôle des protéoglycannes dans la mise en place des voies mésostriatales chez le rat
001292 V. Ben [France] ; O. Blin [France] ; B. Bruguerolle [France]Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions
001299 F. Esclaire [France] ; G. Kisby [États-Unis] ; P. Spencer [États-Unis] ; J. Milne [États-Unis] ; M. Lesort [France] ; J. Hugon [France]The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates Tau mRNA expression and excitotoxicity
001302 M. Vila [France] ; C. Marin [Espagne] ; M. Ruberg [France] ; A. Jimenez [Espagne] ; R. Raisman-Vozari [France] ; Yves Agid [France] ; E. Tolosa [Espagne] ; E. C. Hirsch [France]Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia
001323 R. S. El-Bacha [France] ; P. Netter [France] ; A. Minn [France]Mechanisms of apomorphine cytoxicity towards rat glioma C6 cells : protection by bovine serum albumin and formation of apomorphine-protein conjugates
001332 M. G. Murer [Argentine] ; J. Ferrario [Argentine] ; M. Delfino [Argentine] ; G. Dziewczapolski [Argentine] ; O. S. Gershanik [Argentine] ; R. Raisman-Vozari [France]Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions
001344 O.-K. Hassani [France] ; J. Feger [France]Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats : An electrophysiological and C-fos study
001351 F. A. Dajas-Bailador [Uruguay] ; M. Asencio [Chili] ; C. Bonilla [Uruguay] ; M. C. Scorza [Uruguay] ; C. Echeverry [Uruguay] ; M. Reyes-Parada [Uruguay] ; R. Silveira [Uruguay] ; P. Protais [France] ; G. Russell [Nouvelle-Zélande] ; B. K. Cassels [Chili] ; F. Dajas [Uruguay]Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission
001363 A. Sanchez-Capelo [France] ; O. Corti [France] ; J. Mallet [France]Adenovirus-mediated over-expression of TGFβ1 in the striatum decreases dopaminergic cell survival in embryonic nigral grafts
001377 Synthèse de radioligands marqués au brome-76 et au carbone-11 pour l'étude des récepteurs N-Méthyl-D-Aspartate par Tomographie d'Emission de Positons
001413 P. Emond [France] ; L. Farde [Suède] ; S. Chalon [France] ; C. Belzung [France] ; V. Mauclaire [France] ; J. P. Chiron [France] ; C. Halldin [Suède] ; C. Besnard [France] ; D. Guilloteau [France]Toxicity, mutagenicity, and behavioral effects of β-CIT, a ligand for dopamine transporter exploration by SPECT
001433 E. X. Albuquerque [États-Unis, Brésil] ; E. F. R. Pereira [États-Unis] ; M. F. M. Braga [États-Unis, Brésil] ; H. Matsubayashi [États-Unis] ; M. Alkondon [États-Unis]Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine
001445 L. Vercueil [France] ; A. Benazzouz [France] ; C. Deransart [France] ; K. Bressand [France] ; C. Marescaux [France] ; A. Depaulis [France] ; A. L. Benabid [France]High-frequency stimulation of the sub-thalamic nucleus suppresses absence seizures in the rat : comparison with neurotoxic lesions
001453 P. Morel [France] ; C. Tallineau [France] ; R. Pontcharraud [France] ; A. Piriou [France] ; F. Huguet [France]Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes
001463 M. G. Murer [France] ; G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. C. Garcia [Argentine] ; Yves Agid [France] ; O. Gershanik [Argentine] ; R. Raisman-Vozari [France]Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions
001470 Toxicité du glutamate sur des cultures primaires de neurones mésencéphaliques de la substance noire
001474 CONTRÔLE DE L'EXCITABILITÉ DES NEURONES DOPAMINERGIQUES DE LA SUBSTANCE NOIRE COMPACTE DE RAT PAR LES CATÉCHOLAMINES ET LES NEUROPEPTIDES
001477 Développement de médicaments radiopharmaceutiques émetteurs de rayonnements gamma pour l'exploration du transporteur de la dopamine dans le système nerveux central
001480 Caractérisation des mécanismes mis en jeu dans les effets de la lésion de la voie nigro-striée dopaminergique sur des populations neuronales identifiées du striatum, chez le rat. Approche morphologique combinant des techniques d'immunohistochimie et d'hybridation in situ quantitatives
001481 CONTROLE DOPAMINERGIQUE DU NOYAU SYBTHALAMIQUE CHEZ LE RAT NORMAL ET CHEZ LE RAT MODELE DE LA MALADIE DE PARKINSON (RATS 6-OHDA)
001565 A. Madjid Belkadi [France] ; C. Geny [France] ; S. Naimi [France] ; R. Jeny [France] ; M. Peschanski [France] ; D. Riche [France]Maturation of fetal human neural xenografts in the adult rat brain
001566 F. Huguet [France] ; G. Page [France] ; P. Morel [France] ; C. Tallineau [France] ; A. Piriou [France]MPTP toxicity in rat striatal slices : dopamine uptake alteration does not appear to be related to lipid peroxidation
001571 M. Barkats [France] ; N. Nakao [Suède] ; E. M. Grasbon-Frodl [Suède] ; A. Bilang-Bleuel [France] ; F. Revah [France] ; J. Mallet [France] ; P. Brundin [Suède]Intrastriatal grafts of embryonic mesencephalic rat neurons genetically modified using an adenovirus encoding human Cu/Zn superoxide dismutase
001572 F. G. Kaddis [États-Unis] ; E. D. Clarkson ; M. J. Weber [France] ; D. J. Vandenbergh [États-Unis] ; D. M. Donovan [États-Unis] ; J. Mallet [France] ; P. Horellou [France] ; G. R. Uhl [États-Unis] ; C. R. FreedIntrastriatal grafting of cos cells stably expressing human aromatic L-amino acid decarboxylase : Neurochemical effects
001580 L. J. Anghileri [France] ; P. Thouvenot [France] ; A. Bertrand [France]Effects of iron complexes on brain calcium homeostasis
001582 F. Coudore [France] ; F. Durif [France] ; E. Duroux [France] ; A. Eschalier [France] ; J. Fialip [France]Effect of tolcapone on plasma and striatal apomorphine disposition in rats
001593 J. M. Deniau [France] ; A. M. Thierry [France]Anatomical segregation of information processing in the rat substantia nigra pars reticulata
001599 G. Dziewczapolski [Argentine] ; G. Murer [France] ; Yves Agid [France] ; O. S. Gershanik [Argentine] ; R. Raisman-Vozari [France]Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats
001603 Synthèse et pharmacologie de nouveaux inhibiteurs de la monoamine oxydase B
001639 S. Naimi [France] ; R. Jeny [France] ; P. Hantraye [France] ; M. Peschanski [France] ; D. Riche [France]Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain
001641 P. Barneoud [France] ; M. Mazadier [France] ; J.-M. Miquet [France] ; S. Parmentier [France] ; P. Dubedat [France] ; A. Doble [France] ; A. Boireau [France]Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat
001647 O.-K. Hassani [France] ; M. Mouroux [France] ; J. Feger [France]Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus
001657 V. Blanchard [France] ; P. Anglade [France] ; G. Dziewczapolski ; M. Savasta [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra
001664 P. P. Michel [France] ; Yves Agid [France]Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons
001665 L. Taupenot [France] ; J. Ciesielski-Treska [France] ; G. Ulrich [France] ; S. Chasserot-Golaz [France] ; D. Aunis [France] ; M.-F. Bader [France]Chromogranin a triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells
001666 B. Brugg [France] ; P. P. Michel ; Yves Agid [France] ; M. RubergCeramide induces apoptosis in cultured mesencephalic neurons
001670 F. N. Bolkenius [France] ; J. Verne-Mismer [France] ; J. Wagner [France] ; J. M. Grisar [France]Amphiphilic α-tocopherol analogues as inhibitors of brain lipid peroxidation
001673 Etude de la plasticité des neurones dopaminergiques du mésencéphale ventral dans un modèle expérimental de la phase préclinique de la maladie de Parkinson: adaptations à long terme de la tyrosine hydroxylase et des transporteurs de la dopamine
001678 Utilisation et amélioration de l'adénovirus en tant que vecteur viral pour le tranfert de gènes
001701 P. Horellou [France] ; E. Vigne ; M.-N. Castel ; P. Barneoud ; M. Perricaudet ; P. Delaere ; J. MalletTransplantation of cells genetically modified and direct intracerebral gene transfer with an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease
001705 L. Lebreton [France] ; O. Curet [France] ; S. Gueddari [France] ; FATHI MAZOUZ [France] ; S. Bernard [France] ; C. Burstein [France] ; R. Milcent [France]Selective and potent monoamine oxidase type B inhibitors : 2-substituted 5-aryltetrazole derivatives
001707 ABDELHAMID BENAZZOUZ [France] ; B. Piallat ; P. Pollak ; A.-L. BenabidResponses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats : electrophysiological data
001719 C. Geny [France] ; SOUAD NAIMI-SADAOUI [France] ; ABD EL MADJID BELKADI [France] ; R. Jeny [France] ; MOURAD KAMMOUN [France] ; M. Peschanski [France]Microglial chimaerism in human xenografts to the rat brain
001722 V. Blanchard [France] ; M. Chritin ; SHEELA VYAS [France] ; M. Savasta ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; R. Raisman-Vozari [France]Long-term induction of tyrosine hydroxylase expression : compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain
001724 F. N. Bolkenius [France] ; D. MonardInactivation of protease nexin-1 by xanthine oxidase-derived free radicals
001728 P. Barneoud [France] ; S. Parmentier ; M. Mazadier ; J. M. Miquet ; A. Boireau ; P. Dubedat ; J.-C. BlanchardEffects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat
001734 C. Jolivalt [France] ; A. Minn [France] ; M. Vincent-Viry [France] ; M.-M. Galteau [France] ; G. Siest [France]Dextromethorphan O-demethylase activity in rat brain microsomes
001737 B. Lannes [France] ; V. Bernard [France] ; B. Bloch [France] ; G. Micheletti [France]Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene
001752 Etude neuroanatomique de l'expression du récepteur dopaminergique D2 et de la préproenképhaline dans le striatum de rat après dénervation dopaminergique totale ou partielle et greffe de mésencéphale embryonnaire
001786 A. Boireau [France] ; J.-M. Miquet ; P. Dubedat ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism : partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo
001807 P. Horellou [France] ; E. Vigne [France] ; M.-N. Castel [France] ; P. Barneoud [France] ; P. Colin [France] ; M. Perricaudet [France] ; P. Delaere [France] ; J. Mallet [France]Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease
001817 Etude des transplants de neurones dopaminergiques embryonnaires dans le striatum de rat adulte. Approche multidisciplinaire: immunocytochimique, biochimique et comportementale
001901 Synthèses chimiques et études biochimiques de nouveaux inhibiteurs réversibles et sélectifs des monoamines oxydases A et B. Marquage d'un IMAO B à l'iode 125 et étude de sa biodistribution
001945 P. P. Michel [France] ; S. Vyas ; Yves Agid [France]Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains
001947 P. P. Michel [France] ; Yves Agid [France]The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures
001955 F. Lisovoski [France] ; C. Haby [France] ; E. Borrelli [France] ; C. Schleef ; M.-O. Revel ; C. Hindelang ; J. ZwillerInduction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model
001979 S. Ammar [France] ; P. MartinModélisations des effets des agonistes dopaminergiques en psychopharmacologie : vers une homothétie clinique et expérimentale
001A19 P. Horellou [France] ; C. Lundberg ; B. Le Bourdelles ; K. Wictorin ; P. Brundin ; P. Kalen ; A. Björklund ; J. MalletBehavioural effects of genetically engineered cells releasing DOPA and dopamine after intracerebral grafting in a rat model of Parkinson's disease
001A60 M. Ruberg ; W. Mayo ; A. Brice ; C. Duyckaerts ; J. J. Hauw ; H. Simon ; M. Lemoal ; Yves Agid [France]Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions
001A64 J. Hugon [France] ; J. M. VallatAbnormal distribution of phosphorylated neurofilaments in neuronal degeneration induced by kainic acid
001A86 P. Manei ; D. Wion ; A. Pouplard-Barthelaix ; P. Brachet ; D. Fournier ; G. Alhayek ; P. Mercier ; G. GuyGreffe intra-cérébrale d'une lignée de cellules chromaffines: aspects immunologiques et rôle du nerve growth dans la survie et la différenciation du greffon

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024